/A - Topical treatment of plaque psoriasis with three doses of JB991.

Synphora AB0 个研究点开始时间: 2006年8月29日最近更新: 2012年3月19日

试验速览

暂无简介。

•Post-menopausal females of Caucasian race, aged below 80 years with mild to moderate chronic plaque psoriasis on arms, legs or trunk diagnosed at least one year prior to baseline visit. Two symmetrical lesions must be separated from each other and within reach of application. Written informed consent obtained at pre-study visit at the latest (before ECG and laboratory tests).
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range

•Any other relevant skin disorder that may affect the study. Use of systemic psoriasis medications, phototherapy or topical medications on the plaque to be treated with study medication within the past month prior to baseline day (Day 1). (Lesions on the same extremities as those to be treated with study medication should not be treated with local medication during the study. Other lesions may be treated locally with approved psoriatic medication used within the last month prior to Day 1). Emollients may be used up to 1 day before treatment start on the plaque to be treated and throughout the study on all other lesions. Patients with severe allergy and /or severe bronchial asthma. Any clinically relevant laboratory value outside the normal range, or deviating ECG. Hypersensitivity to any of the components in the study drugs. Participation in any other clinical trial within one month prior to Day 1. Alcohol or drug abuse.

发起方